Institutional investors lightened up their holdings of AGN shares during the quarter ended --, as they sold a net -- shares. Additionally, the 0.00% of shares outstanding that they still hold represents the lowest percentage for any company in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RINGELSTEIN UND PARTNER VERMÖGEN... Bought 2.0 Thousand shares of Allergan